If you are not aware this is the treatment used for Herpes and all of this began back in 2005, so how long these legal issues go on and all the money spent, which 
ends up coming down the line to use as consumers in what we pay for drugs. I think these long legal court battles that keep the price of drugs elevated are beginning to become fashionably not popular. Back in 2007 a judge ruled that Novartis' patent was also deemed unenforceable and the FDA approved the generic version as well.
So it appears all the money spent on this patent conflict has been resolved. You wonder how long these items can do on sometimes, 5 years on this one and Teva is in a pretty good spot it sounds overall, but the amount of the one time payment was not disclosed and who knows how big the royalties are to be paid, so in essence there’s still money going back to Novartis. Drug stores will be happy though. BD
Generic Drugs Yield Higher Profit Margins for Pharmacies Than Name Brands – Patients Save Money Too
JERUSALEM, Feb 15, 2010 (BUSINESS WIRE) -- Teva Pharmaceutical Industries Ltd. today announced that its subsidiary, Teva Pharmaceuticals USA, Inc., has signed an agreement with Novartis to settle patent litigation involving Teva's U.S. generic version of Novartis' Famvir(R) (famciclovir) 125 mg, 250 mg and 500 mg tablets including all claims for patent infringement and damages. Teva launched its generic famciclovir tablets in the U.S. in September 2007.
The present agreement releases Teva for all past and future activities in connection with the U.S. marketing and sale of Teva's generic famciclovir tablets. Under the terms of the agreement, Teva will make a one-time payment to Novartis in addition to an ongoing royalty on U.S. sales of generic famciclovir.
Teva Announces Agreement on Famvir(R) Patent Challenge - MarketWatch
0 comments :
Post a Comment